Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Disease
  4. /
  5. Pulmonary alveolar proteinosis- acquired

Pulmonary alveolar proteinosis- acquired

December 31, 2014

Related News

  • Savara’s Phase 3 IMPALA-2 Trial of Inhaled Molgramostim in Autoimmun
  • Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosi
  • Researchers at Rockefeller University uncover a genetic malfunction th
  • Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test
  • Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pul
More News

Related Clinical Trial

  • A National Registry For Pulmonary Alveolar Proteinosis
  • The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveola
  • Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary A
  • Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulat
More Clinical Trial

Latest Research

  • 50 years WATL (Scientific Working Group for the Therapy of Lung Diseases)
  • A case of autoimmune pulmonary alveolar proteinosis appearing as a localized ground-glass opacity
  • A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis
  • A Case of Autoimmune Pulmonary Alveolar Proteinosis with Pulmonary Fibrosis and Asbestosis-Like Features
  • A crazy cause of dyspnea
More Research
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo